MiMedx Group Inc (MDXG)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

1775 W OAK COMMONS COURT, NE MARIETTA, GA 30062

MiMedx Group, Inc., a development stage company, focuses on developing products primarily for use by musculoskeletal specialists in surgical and non-surgical therapy. The company's MiMedx platform technology is a NDGA polymerization chemistry to treat tendon and ligament trauma. Its portfolio focuses on motion-preserving spine technologies, soft-tissue repair, and extremities-small bone and joint implants.

Data as of 2020-11-22
Market Cap734.01 Million Shares Outstanding111.045 Million Avg 30-day Volume377.395 Thousand
P/E Ratio-9.9 Dividend Yield EPS-0.67
Price/Sales2.866 Price cash flow ratio15.9 Price free cash flow ratio-15.9
Book Value0.12 Price to Tangible Book-51.42 Alpha0.01
Short Interest Ratio % Short Interest to Float R-squared0.071862
BETA1.54075 52-week High/Low7.95 / 2.95 Stddev0.242205
View SEC Filings from MDXG instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 18 17 5.88% 6 (0.39%) 5 (0.32%) 20.0%
13F shares: 4.518 Million 4.516 Million 0.04% 3.813 Million 3.69 Million 3.35%
% Ownership 4.096 4.0942 0.04% 3.4573 3.3454 3.34%
New Positions: 2 2 0.0% 1 1 0.0%
Increased Positions 1
Closed Positions 3 2
Reduced Positions 5 3 66.67% 3 1 200.0%
Total Calls 0
Total Puts 0
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MDXG (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MDXG BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CARLSON PETER M CHIEF FINANCIAL OFFICER

  • Officer
297,683 2020-11-04 5

PHELAN WILLIAM LAWRENCE CHIEF ACCOUNTING OFFICER

  • Officer
67,796 2020-11-04 3

TURNER SCOTT M SVP, OPERATIONS & PROCUREMENT

  • Officer
152,677 2020-10-26 4

KOOB CHARLES E

  • Director
1,431,525 2020-10-02 4

EVANS CHARLES ROBERT

  • Director
121,357 2020-10-02 2

YESTON NEIL

  • Director
126,357 2020-10-02 2

BIERMAN JAMES L

  • Director
64,371 2020-10-02 2

BEHRENS M KATHLEEN

  • Director
64,371 2020-10-02 2

NEWTON TODD

  • Director
64,371 2020-10-02 2

HAWKINS WILLIAM A

  • Director
39,654 2020-10-02 4

STEIN ROBERT BENJAMIN EVP, RESEARCH AND DEVELOPMENT

  • Officer
81,833 2020-08-10 2

DEWBERRY J TERRY

  • Director
156,787 2020-08-05 1

WRIGHT TIMOTHY R CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,164,260 2020-08-05 2

BARRY RICHARD

  • Director
3,338,135 2020-08-05 1

HULSE WILLIAM FRANK IV GENERAL COUNSEL

  • Officer
120,762 2020-08-05 2

GRAVES MARK SVP & CHIEF COMPLIANCE OFFICER

  • Officer
79,989 2020-08-05 3

KASHYAP ROHIT EVP & CHIEF COMMERCIAL OFFICER

  • Officer
173,310 2020-08-03 2

SUTTER MARTIN P

  • Director
  • 10% Owner
23,377,123 2020-07-02 2

FALCON FUND 2 HOLDING COMPANY, L.P.

  • 10% Owner
0 2020-07-02 1

LANDY MARK EVP & CHIEF STRATEGY OFFICER

  • Officer
379,925 2019-07-25 0

BLESER JOSEPH G

  • Director
181,545 2019-06-20 0

HACK BRUCE

  • Director
769,728 2019-06-07 0

HADEN ALEXANDRA O GENERAL COUNSEL & SECRETARY

  • Officer
154,504 2019-02-22 0

BORKOWSKI EDWARD EVP & INTERIM CFO

  • Officer
191,166 2019-02-21 0

OKUMUS FUND MANAGEMENT LTD.

OKUMUS OPPORTUNISTIC VALUE FUND LTD.

OKUMUS AHMET H

  • 10% Owner
21,066,710 2019-01-22 0

PAPASAN LARRY W

  • Director
140,158 2018-12-31 0

AGUILAR LUIS A

  • Director
25,333 2018-12-31 0

COLES DAVID JAMES INTERIM CHEF EXECUTIVE OFFICER

  • Officer
0 2018-07-02 0

TAYLOR WILLIAM CHARLES PRESIDENT AND COO

  • Officer
  • Director
557,057 2018-02-27 0

PETIT PARKER H CHAIRMAN & CEO

  • Officer
  • Director
4,647,422 2018-02-22 0

SENKEN MICHAEL J. CHIEF FINANCIAL OFFICER

  • Officer
273,530 2018-02-22 0

MCCAW ROBERTA L GENERAL COUNSEL AND SECRETARY

  • Officer
193,247 2015-02-18 0

GORLIN STEVE

  • Director
898,145 2013-05-16 0

EICHLER KURT M

  • Director
663,406 2012-07-27 0

ROOKE ANDREW K. JR.

  • Director
0 2011-12-14 0

KOOB THOMAS J CHIEF SCIENTIFIC OFFICER

  • Officer
0 2011-03-18 0

BROWN REBECCAH COVERT

  • EVP, PRODUCT DEVELOPMENT
0 2010-02-23 0

MILLER MATTHEW JERGESEN EVP

  • Officer
0 2009-12-30 0

CULUMBER MICHAEL J. CHIEF FINANCIAL OFFICER

  • Officer
52,462 2009-12-29 0

FOCHT LOUISE

  • SENIOR VICE PRESIDENT
0 2009-07-31 0

WALLACE RONALD G.

  • Director
498,891 2008-04-29 0

JORDAN HAMILTON

  • Director
1,700,281 2008-02-08 0

THOMAS JOHN C CFO & SECRETARY

  • Officer
5,267,492 2008-02-08 0

BENNETT RUFUS LEWIS SR PRESIDENT OF SUBSIDIARY

  • Officer
150,000 2008-02-08 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

PHELAN WILLIAM LAWRENCE - Officer CHIEF ACCOUNTING OFFICER

2020-11-05 16:08:15 -0500 2020-11-04 A 8,474 $7.23 a 67,796 direct -3.0596 0.9662 0.9662 6 -6.9243 4

CARLSON PETER M - Officer CHIEF FINANCIAL OFFICER

2020-11-05 16:04:46 -0500 2020-11-04 A 35,211 $7.23 a 297,683 direct -3.0596 0.9662 0.9662 6 -6.9243 4

TURNER SCOTT M - Officer SVP, OPERATIONS & PROCUREMENT

2020-10-28 08:46:27 -0400 2020-10-26 F 301 $5.91 d 152,677 direct -0.8621 24.6552 24.6552 6 -8.2759 3

YESTON NEIL - Director

2020-10-05 16:15:58 -0400 2020-10-02 A 26,236 $6.67 a 126,357 direct -1.6641 1.9667 0.7564 9.3797 22 -19.5159 19

BIERMAN JAMES L - Director

2020-10-05 16:10:31 -0400 2020-10-02 A 26,236 $6.67 a 64,371 direct -1.6641 1.9667 0.7564 9.3797 22 -19.5159 19

KOOB CHARLES E - Director by family trust

2020-10-05 16:13:52 -0400 2020-10-02 A 26,236 $6.67 a 1,431,525 indirect -1.6641 1.9667 0.7564 9.3797 22 -19.5159 19

EVANS CHARLES ROBERT - Director

2020-10-05 16:11:50 -0400 2020-10-02 A 26,236 $6.67 a 121,357 direct -1.6641 1.9667 0.7564 9.3797 22 -19.5159 19

NEWTON TODD - Director

2020-10-05 16:14:50 -0400 2020-10-02 A 26,236 $6.67 a 64,371 direct -1.6641 1.9667 0.7564 9.3797 22 -19.5159 19

BEHRENS M KATHLEEN - Director

2020-10-05 16:09:18 -0400 2020-10-02 A 26,236 $6.67 a 64,371 direct -1.6641 1.9667 0.7564 9.3797 22 -19.5159 19

HAWKINS WILLIAM A - Director

2020-10-05 16:12:50 -0400 2020-10-02 A 26,236 $6.67 a 39,654 direct -1.6641 1.9667 0.7564 9.3797 22 -19.5159 19

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments